30 September 2025
Harena Resources Plc
("Harena" or the "Company")
Total Voting Rights
Harena Resources Plc (LSE: HREE), the rare earths company focused on the Ampasindava ionic clay rare earth project in Madagascar (the " Ampasindava Project "), announces that the issued share capital of the Company as at the date of this announcement comprises 562,651,018 ordinary shares of 0.5 pence each with one voting right per share ("Ordinary Shares"). The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 562,651,018.
This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules of the UK Financial Conduct Authority.
For further information please contact:
| Harena Resources Plc Ivan Murphy, Non-Executive Chairman Allan Mulligan, Executive Technical Director
|
+44 (0)20 7770 6424
|
|
Allenby Capital Limited - Financial Adviser & Joint Broker Jeremy Porter / Vivek Bhardwaj (Corporate Finance) Amrit Nahal / Kelly Gardiner (Sales & Corporate Broking)
|
+44 (0)20 3328 5656 |
| Celicourt Communications - Public Relations Mark Antelme / Charles Denley-Myerson |
+44 (0)20 7770 6424 harena @celicourt.uk |
Notes to editors
Harena ( www.harenaresources.com.au ) is a rare earths exploration and development company focused on the Ampasindava Ionic Clay Rare Earth Project in Madagascar (Harena's interest is 100%). The project hosts one of the largest ionic clay rare earth deposits outside of China, with significant concentrations of high-value magnet metals. Harena is committed to low-impact, high recovery mining, providing a sustainable supply of critical minerals for the global energy transition and military defence industries. Forward-Looking Statements This announcement contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those expressed or implied in such statements.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.